Bristol Myers Squibb (BMY) Profit After Tax (2009 - 2026)

Bristol Myers Squibb (BMY) has 18 years of Profit After Tax data on file, last reported at $2.7 billion in Q1 2026.

• Profit After Tax for Q1 2026 came in at $2.7 billion, up 8.77% year-over-year; the trailing twelve-month figure through Mar 2026 was $6.0 billion (up 10.1% YoY), and the FY2025 annual result was $7.1 billion, up 178.83% from the prior year.
• Profit After Tax rose to $2.7 billion in Q1 2026 per BMY's latest filing, from $1.1 billion in the prior quarter.
• Over five years, Profit After Tax peaked at $2.7 billion in Q1 2026 and troughed at -$11.9 billion in Q1 2024.
• A 5-year average of $485.4 million and a median of $1.4 billion in 2022 frame the typical range for Profit After Tax.
• On a YoY basis, Profit After Tax climbed as much as 41900.0% in 2024 and fell as far as 238320.0% in 2024.
• A 5-year view of Profit After Tax shows it stood at $2.0 billion in 2022, then slipped by 13.63% to $1.8 billion in 2023, then plunged by 96.54% to $61.0 million in 2024, then surged by 1677.05% to $1.1 billion in 2025, then soared by 147.05% to $2.7 billion in 2026.
• Business Quant data shows BMY's Profit After Tax at $2.7 billion in Q1 2026, $1.1 billion in Q4 2025, and $2.2 billion in Q3 2025.